The perfect match for screening hemoglobin disorders in newborns.
Every day more than one hundred thousand newborns are screened worldwide for metabolic and endocrine disorders. Although screening for hemoglobin has a long history in some countries (USA or UK), in other countries it is a recent addition to their screening panels (Portugal; Germany).
The increase of hemoglobin disorders in regions that previously did not see them has raised awareness of the importance of screening for them in newborns.
Early screening has proven to be effective in improving the lives of babies by providing appropriate treatment and follow-up.
Key Benefits
Ease of use: All the steps are managed automatically by the instrument; it is easy to operate and requires few maintenance procedures.
Automatic result interpretation: Samples are automatically identified as normal or abnormal by the software, allowing laboratories to quickly detect and identify pathological results and quickly releasing non-pathological samples.
Excellent resolution: Thanks to Sebia Capillarys’ high resolution hemoglobins separation, the instrument allows the display of a clear profile, enabling easy identification of abnormal hemoglobin variants (S, C, D and E…) as well as abnormalities arising from thalassemia (Hb H, Hb Bart’s).
Early detection: Early detection of hemoglobin disorders allows appropriate treatment and follow up, improving the infant’s life while reassuring parents.
Main Characteristics
Test Principle
The CAPI 3 NEONAT Hb kit is intended for the detection of normal hemoglobins (F and A) and abnormal hemoglobin (S, C, D, E and Bart’s) in blood from newborns collected on filter paper. This qualitative analysis is performed by capillary electrophoresis with the CAPILLARYS 3 DBS automated instrument.
Sample Type
Dried neonatal blood spots – Samples are punched (at 3.2 mm size), eluted in distilled water and analysed directly on the CAPILLARYS 3 DBS instrument.
